We will beat
childhood cancer
by funding novel research and innovative clinical trials utilizing precision medicine to target solid tumors in children.
Together, we will beat childhood cancer.
Childhood cancer is not yet beaten.
Children are being diagnosed with cancer every day, and several childhood cancer types have heartbreakingly low survival rates. New treatment options (within reach for families), and a deeper understanding of how these tumors work are desperately needed.
What we are doing is working. Here's how we work to beat childhood cancer:
Research Infrastructure
The Beat Childhood Cancer Research Consortium (50+ children's hospitals) working to discover, design, and enroll kids on bold clinical trials.
Precision Medicine
Understanding how and why of each tumor to create personalized treatment plans.
RECENT NEWS:
DFMO IS NOW FDA APPROVED!
On December 13, 2023, the FDA announced the approval of DFMO! Now named "IWILFIN", it is the first pediatric neuroblastoma drug to reduce the risk of relapse for pediatric neuroblastoma patients. This less toxic, life-saving drug will now be available to every child, everywhere!
Click to read the recent article HERE
Beat Childhood Cancer was founded by parents.
Our Vision: Change the story for the next family to help every child, everywhere survive and thrive.